Sell RIMM! Against ...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$41.61 -0.07 | -0.17%
02/03/12 - 04:00 PM ET
1.23M / 798.90K
Vol / Avg. Vol:42.00 / 41.68
Open / Prev. Close:41.54 - 42.39
Today's Range:21.39 - 42.14
52 Wk Range:5.02%
Performance YTD:TheStreet Rating:
Portfolios with CBST
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ProJoel Greenblatt - Gotham Ca...
- ContributorEarnings Short Squeeze Play...
- ContributorJefferies' 6 Best Health-Ca...
- ContributorTheStreet Ratings Top-Rated...
- Userklong231 Portfolio 1
Latest CBST Headlines from TheStreet
- Cubist Stock Hits New 52-Week High (CBST) 02.03.12 | 10:02 am
- TheStreet Ratings Top 10 Rating Changes 01.23.12 | 12:01 pm
- Cubist Pharmaceuticals Inc. Stock Downgraded (CBST) 01.23.12 | 05:01 am
- 5 Stocks Set to Soar on Bullish Earnings 01.18.12 | 03:01 pm
- Cubist Stock Hits New 52-Week High (CBST) 01.17.12 | 11:01 am
- 'Mad Money Lightning Round': Biogen Shines 01.10.12 | 07:01 pm
- Cramer's 'Mad Money' Recap: Maintaining Market Discipline (Update 2) 01.10.12 | 06:01 pm
- Cubist Reaches New 52-Week High (CBST) 01.06.12 | 12:01 pm
- After Not-So-Magic 2011, Brighter Outlook 12.28.11 | 10:12 am
- Cubist CEO: We are not Pfizer
10.25.11 | 12:10 pm
Press Releases for CBST
- Cubist Pharmaceuticals Reports 2011 Fourth Quarter And Full Year Financial Results - Business Wire 01.19.12 | 04:01 pm
- Http://www.hydrabiosciences.com/ - Business Wire 01.10.12 | 08:01 am
- Cubist Announces Full Year 2011 Total CUBICIN Net Product Revenues Of $735.5 Million, Up 18% Over 2010 - Business Wire 01.09.12 | 08:01 am
- Cubist Pharmaceuticals And The New England Patriots Radio Network Honor Merrimack, New Hampshire, Science Teacher - Business Wire 01.04.12 | 01:01 pm
- Cubist Announces First Patient Dosed In Pivotal Global Phase 3 Trial Of CXA-201 For Complicated Intra-Abdominal Infections - Business Wire 12.13.11 | 08:12 am
- Www.adolor.com - Business Wire 12.12.11 | 09:12 am
- Cubist Pharmaceuticals Announces Results Of Initial Tender Offer For Outstanding Shares Of Adolor Corporation And Commencement Of Subsequent Offering Period - Business Wire 12.07.11 | 07:12 am
- Cubist Pharmaceuticals To Present At December 2011 Investor Conferences - Business Wire 11.29.11 | 11:11 am
- Http://www.adolor.com - Business Wire 11.15.11 | 08:11 am
- Cubist Pharmaceuticals Commences Tender Offer For All Outstanding Shares Of Adolor - Business Wire 11.07.11 | 08:11 am
Partner Headlines for CBST
- 10 Stocks That Made New Highs On Friday: Hedging Costs - Seeking Alpha 01.15.12 | 07:01 am
- Cubist's Preliminary Sales Impress - Analyst Blog - Zacks 01.11.12 | 10:01 am
- Alnylam States Preclinical Data - Analyst Blog - Zacks 12.30.11 | 04:12 pm
- Healthcare Sector: Noteworthy Buys And Sells By Insiders Last Week - Seeking Alpha 11.01.11 | 09:11 am
- Company News for October 25, 2011 - Corporate Summary - Zacks 10.25.11 | 10:10 am
- Morning Market Movers - Benzinga 10.24.11 | 09:10 am
- Pipeline Progress at Alnylam - Analyst Blog - Zacks 10.06.11 | 05:10 pm
- Neutral on Theravance - Analyst Blog - Zacks 08.17.11 | 05:08 pm
- Bullish on Optimer Pharma - Analyst Blog - Zacks 08.15.11 | 06:08 pm
- Cubist Pharmaceuticals Bid Higher on Earnings Results - Benzinga 07.14.11 | 04:07 pm
